Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 1 , Pages 45-54 , July 2010

Elevated plasma fibrinogen caused by inadequate α-linolenic acid intake can be reduced by replacing fat with canola-type rapeseed oil

  • T. Seppänen-Laakso

      Affiliations

    • Division of Pharmaceutical Biology, Faculty of Pharmacy, University of Helsinki, Finland
    • VTT Technical Research Centre of Finland, Espoo, Finland
    • ,
  • I. Laakso

      Affiliations

    • Division of Pharmaceutical Biology, Faculty of Pharmacy, University of Helsinki, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358919159185; fax: +358919159138.
    • ,
  • T. Lehtimäki

      Affiliations

    • Laboratory of Atherosclerosis Genetics, Tampere University Hospital, Centre for Laboratory Medicine, and Department of Clinical Chemistry, Medical School, University of Tampere, Finland
    • ,
  • R. Rontu

      Affiliations

    • Laboratory of Atherosclerosis Genetics, Tampere University Hospital, Centre for Laboratory Medicine, and Department of Clinical Chemistry, Medical School, University of Tampere, Finland
    • ,
  • E. Moilanen

      Affiliations

    • The Immunopharmacology Research Group, Medical School, University of Tampere, and Research Unit, Tampere University Hospital, Finland
    • ,
  • T. Solakivi

      Affiliations

    • Department of Medical Biochemistry, Medical School, University of Tampere, Finland
    • ,
  • L. Seppo

      Affiliations

    • Foundation for Nutrition Research, Finland
    • Institute of Biomedicine, University of Helsinki, Finland
    • Deceased
    • ,
  • H. Vanhanen

      Affiliations

    • The Social Insurance Institution of Finland, Helsinki, Finland
    • ,
  • K. Kiviranta

      Affiliations

    • Skin and Allergy Hospital, Helsinki University Central Hospital, Finland
    • ,
  • R. Hiltunen

      Affiliations

    • Division of Pharmaceutical Biology, Faculty of Pharmacy, University of Helsinki, Finland

Received 20 December 2008 ,Revised 23 November 2009 ,Accepted 2 February 2010.

References 

  1. Lands WEM. Diets could prevent many diseases. Lipids. 2003;38:317–321
  2. Crawford MA. Background to essential fatty acids and their prostanoid derivatives. Br. Med. Bull. 1983;39:210–213
  3. Leaf A, Kang JX. ω3 Fatty acids and cardiovascular disease. In:  Simopoulos AP editors. The Return of ω3 Fatty Acids into the Food Supply. Basel: Karger; 1998;p. 24–37
  4. Lands WEM. Primary prevention in cardiovascular disease: moving out of the shadows of the truth about death. Nutr. Metab. Cardiovasc. Dis. 2003;13:154–164
  5. Lands B. A critique of paradoxes in current advice on dietary lipids. Prog. Lipid Res. 2008;47:77–106
  6. Marckmann P, Grønbæk M. Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur. J. Clin. Nutr. 1999;53:585–590
  7. Erkkilä AT, Lehto S, Pyörälä K, Uusitupa MU. n-3 Fatty acids and 5-y risk of death and cardiovascular disease events in patients with coronary artery disease. Am. J. Clin. Nutr. 2003;78:65–71
  8. Burr ML, Ashfield-Watt PAL, Dunstan FDJ, Fehily AM, Breay P, Ashton T, et al Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur. J. Clin. Nutr. 2003;57:193–200
  9. Louheranta AM, Porkkala-Sarataho EK, Nyyssönen MK, Salonen RM, Salonen JT. Linoleic acid intake and susceptibility of very-low-density and low density lipoproteins to oxidation in men. Am. J. Clin. Nutr. 1996;63:698–703
  10. Finnegan YE, Minihane AM, Leigh-Firbank EC, Key S, Meijer GW, Muggli R, et al. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 2003;77:783–795
  11. Pedersen H, Petersen M, Major-Pedersen A, Jensen T, Nielsen NS, Lauridsen ST, et al. Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes. Eur. J. Clin. Nutr. 2003;57:713–720
  12. Lefevre M, Kris-Etherton PM, Zhao G, Tracy RP. Dietary fatty acids, hemostasis, and cardiovascular disease risk. J. Am. Dietetic Assoc. 2004;104:410–419
  13. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428
  14. Danesh J. The Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality. An individual participant meta-analysis. JAMA. 2005;294:1799–1809
  15. Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques, The Copenhagen City Heart Study. Eur. Heart J. 2003;24:567–576
  16. Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, et al. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes. Diabetes Care. 2003;26:1439–1448
  17. van Oijen M, Witteman JC, Hofman A, Koudstal PJ, Breteler MMB. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke. 2005;36:2637–2641
  18. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br. Med. J. 1994;309:23–27
  19. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Care. 2000;23:1516–1526
  20. Parillo M, Riccardi G. Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. Br. J. Nutr. 2004;92:7–19
  21. Seppänen-Laakso T, Vanhanen H, Laakso I, Kohtamäki H, Viikari J. Replacement of butter on bread by rapeseed oil and rapeseed oil-containing margarine. Effects on plasma fatty acid composition and serum lipids. Br. J. Nutr. 1992;68:639–654
  22. Seppänen-Laakso T, Vanhanen H, Laakso I, Kohtamäki H, Viikari J. Replacement of margarine on bread by rapeseed and olive oils. Effects on plasma fatty acid composition and serum lipids. Ann. Nutr. Metab. 1993;37:161–174
  23. Seppänen-Laakso T, Laakso I, Backman P, Vanhanen H, Viikari J. Elaidic and trans-vaccenic acids in plasma phospholipids as indicators of dietary intake of 18:1 trans-fatty acids. J. Chromatogr. B. 1996;687:371–378
  24. Seppänen-Laakso T, Laakso I, Hiltunen R. Analysis of fatty acids by gas chromatography, and its relevance to research on health and nutrition. Anal. Chim. Acta. 2002;465:39–62
  25. Rastas M, Seppänen R, Knuts L-R, Karvetti R-L, Varo P. Nutrient composition of foods. Finland: Publications of the Social Insurance Institution; 1989;
  26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  27. Aejmelaeus R, Metsä-Ketelä T, Laippala P, Solakivi T, Alho H. Ubiquinol-10 and total peroxyl radical trapping capacity of LDL lipoproteins during aging: the effects of Q-10 supplementation. Mol. Aspects Med. 1997;18:S113–S120
  28. Leinonen JS, Rantalaiho V, Solakivi T, Koivula T, Wirta O, Pasternack A, et al. Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients. Clin. Chim. Acta. 1998;275:163–174
  29. Pietinen P, Vartiainen E, Seppänen R, Aro A, Puska P. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev. Med. 1996;25:243–250
  30. Lands WEM. Commentary on the workshop statement. Prostaglandins Leukotrienes Essent. Fatty Acids. 2000;63:125–126
  31. Holman RT, Mohrhauer H. A hypothesis involving competitive inhibitions in the metabolism of polyunsaturated fatty acids. Acta Chem. Scand. 1963;17:S84–S90
  32. Lands WEM, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim. Biophys. Acta. 1992;1180:147–162
  33. Mohrhauer H, Holman RT. The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J. Lipid Res. 1963;4:151–159
  34. Mohrhauer H, Holman RT. Effect of linolenic acid upon the metabolism of linoleic acid. J. Nutr. 1963;81:67–74
  35. Holman RT. The slow discovery of the importance of ω3 essential fatty acids in human health. J. Nutr. 1998;128:427S–433S
  36. Nakamura MT, Cho HP, Xu J, Tang Z, Clarke SD. Metabolism and functions of highly unsaturated fatty acids: an update. Lipids. 2001;36(9):961–964
  37. Seppänen-Laakso T, Laakso I, Vanhanen H, Kiviranta K, Lehtimäki T, Hiltunen R. Major human plasma lipid classes determined by quantitative high-performance liquid chromatography, their variation and associations with phospholipid fatty acids. J. Chromatogr. B. 2001;754:437–445
  38. Emken EA, Adlof RO, Rohwedder WK. R.M. Gulley, Comparison of linolenic and linoleic acid metabolism in man: Influence of dietary linoleic acid. In:  Sinclair A,  Gibson R editor. Essential Fatty Acids and Eicosanoids. Champaign, IL: AOCS; 1992;p. 23–25
  39. Rahm JJ, Holman RT. Effect of linoleic acid upon the metabolism of linolenic acid. J. Nutr. 1964;84:15–19
  40. Bemelmans WJE, Broer J, Feskens EJM, Smit AJ, Muskiet FAJ, Lefrandt JD, et al. Effect of an increased intake of α-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am. J. Clin. Nutr. 2002;75:221–227
  41. Finnegan YE, Howarth D, Minihane AM, Kew S, Miller GJ, Calder PC, et al. Plant and marine derived (n-3) polyunsaturated fatty acids do not affect blood coagulation and fibrinolytic factors in moderately hyperlipidemic humans. J. Nutr. 2003;133:2210–2213
  42. Sanders TAB, Lewis F, Slaughter S, Griffin BA, Griffin M, Davies I, et al. Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of α-linolenic acid, eicosapentaenoic and docosahexaenoic acid, or both on fibrinogen and clotting factors VII and XII in persons aged 45-70 y: the OPTILIPID Study. Am. J. Clin. Nutr. 2006;84:513–522
  43. Sprecher H. Interconversions between 20- and 22-carbon n-3 and n-6 fatty acids via 4-desaturase independent pathways. In:  Sinclair A,  Gibson R editor. Essential Fatty Acids and Eicosanoids. Champaign, IL: AOCS; 1992;p. 18–22
  44. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta. 2000;1486:219–231
  45. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation. 2005;111:157–164
  46. Harris JI, Hibbeln JR, Mackey RH, Muldoon MF. Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins Leukotrienes Essent. Fatty Acids. 2004;71:263–269
  47. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003;169:203–214
  48. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen T-P, Valkonen V-P, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47:1403–1410
  49. Renaud S, Godsey F, Dumont E, Thevenon C, Ortchanian E, Martin JL. Influence of long-term diet modification on platelet function and composition in Moselle farmers. Am. J. Clin. Nutr. 1986;43:136–150
  50. Renaud S, Morazain R, Godsey F, Dumont E, Thevenon C, Martin JL, et al. Nutrients, platelet function and composition in nine groups of French and British farmers. Atherosclerosis. 1986;60:37–48
  51. De Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–1459
  52. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc. Drugs Ther. 1997;11:485–491
  53. Stanley JC, Elsom RL, Calder PC, Griffin BA, Harris WS, Jebb SA, et al. UK Food Standards Agency Workshop Report: the effect of the dietary n-6:n-3 fatty acid ratio on cardiovascular health. Br. J. Nutr. 2007;98:1305–1310
  54. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, et al. n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 2006;84:5–17
  55. Gurr MI. Dietary lipids and coronary heart disease: old evidence, new perspective. Prog. Lipid Res. 1992;31:195–243
  56. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Kumlin T. Fatty acid composition of serum lipids predicts myocardial infarction. Br. Med. J. 1982;285:993–996
  57. International Consensus Statement, Olive Oil and the Mediterranean Diet: Implications for Health in Europe, 16 Authors, European Commission Meeting, Rome, 1997.
  58. Simopoulos AP. Overview of evolutionary aspects of ω3 fatty acids in the diet. In:  Simopoulos AP editors. The Return of ω3 Fatty Acids into the Food Supply. Basel: Karger; 1998;p. 1–11
  59. Freese R, Mutanen M. α-Linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. Am. J. Clin. Nutr. 1997;66:591–598
  60. Johnsson GH, Keast DR, Kris-Etherton PM. Dietary modelling shows that the substitution of Canola oil for fats commonly used in the United States would increase compliance with dietary recommendations for fatty acids. J. Am. Dietetic Assoc. 2007;107:1726–1734

PII: S0952-3278(10)00043-8

doi: 10.1016/j.plefa.2010.02.001

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 1 , Pages 45-54 , July 2010

Article Tools

* Image Usage & Resolution